Reply to the Comment: Research Design Concerns in a TriNetX Analysis of Venous Thromboembolism in Pediatric Cystic Fibrosis Patients [0.03%]
致信：关于儿科囊性纤维化患者静脉血栓栓塞研究设计的疑虑
Dina Ashour,Carolena Trocchia,Maua Mosha Alleyne et al.
Dina Ashour et al.
2025 Eberhard F. Mammen Award Announcements-Part II: Young Investigator Awards [0.03%]
2025埃伯哈德F.Mammen奖公告第二部分：青年 investigator 奖
Emmanuel J Favaloro
Emmanuel J Favaloro
From Acute Thrombosis to Eccentric Neointima in Arteriovenous Fistula [0.03%]
从动静脉内瘘急性血栓形成到偏心性内膜增生的发展过程
Hualong Bai,Zhuo Li,Alan Dardik
Hualong Bai
Thrombosis is a central driver of both early and late arteriovenous fistula (AVF) failure. While symptomatic thrombosis contributes to early AVF occlusion and is treated promptly, the role of asymptomatic mural thrombi in human AVFs remains...
Acquired Hemostasis Disorders [0.03%]
获得性止血缺陷
Antonella Tufano,Massimo Franchini,Antonio Coppola
Antonella Tufano
Neonatal Sepsis-Induced Coagulopathy: An Evolving Frontier at the Crossroads of Inflammation and Hemostasis [0.03%]
新生儿败血症所致的凝血病：炎症与止血交叉路口的一个前沿领域
Rozeta Sokou,Alexandra Lianou,Eleni Gounari et al.
Rozeta Sokou et al.
Sepsis is defined as life-threatening organ dysfunction, caused by a dysregulated host immune response to an infection. Sepsis is often associated with significant hemostatic disorders that may lead to extensive intravascular thrombosis, di...
2026 Eberhard F Mammen Award Announcements: Part I-Most Popular Articles [0.03%]
2026埃伯哈德F.M.马曼奖公告（一）：最受欢迎论文奖
Emmanuel J Favaloro
Emmanuel J Favaloro
Second Report of A GPIbα LRR7 Variant (P.Leu194Phe) Supporting the Pathogenicity of Mutations Outside The C-Terminal Domain In Platelet-Type Von Willebrand Disease [0.03%]
GPIbα LRR7 变体（P.Leu194Phe）的第二份报告：支持 platelet 类型血管性血友病中细胞外末端区域以外突变致病性的证据
Yoann Huguenin,Anne Ryman,Mathieu Fiore
Yoann Huguenin
Thrombin Generation Assays in Clinical Hemostasis: From Mechanistic Insights to Clinical Applications [0.03%]
临床止血中的凝血酶生成检测：从机制研究到临床应用
Joris Godelaine,Christine Van Laer
Joris Godelaine
Background: Thrombin plays a central role in hemostasis, serving as both the primary enzyme driving fibrin formation and central regulator of anticoagulant pathways. Routine coagulation assays such as prothrombin time and...
Charlotte Gran,Sanna Norén,Jovan P Antovic
Charlotte Gran
Coagulopathies are common in hematological malignancies and can cause life-threatening bleeding or thrombosis. Extracellular vesicles (EVs), including exosomes, microvesicles, and apoptotic bodies, carry cargo that reflects their cellular o...
Sam Schulman
Sam Schulman